s6y

MIRA PHARMACEUTICALS, INC.

Ticker
MIRA
CIK
1904286
Industry
Pharmaceutical Preparations
Formerly
Mira1a Therapeutics, Inc.

Financials 17

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K/A Annual Report for period ending Dec 31, 2024
  9. 10-K/A Annual Report for period ending Dec 31, 2024
  10. 10-K Annual Report for period ending Dec 31, 2024

All 17 financials filings

News 75

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 75 news filings

Ownership 59

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 5 Annual statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 59 ownership filings

Prospectus 20

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. S-3 Registration statement for specified transactions by certain issuers
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  10. 424B1 Prospectus filed pursuant to Rule 424(b)(1)

All 20 prospectus filings

Proxies 7

  1. DEF 14A Definitive proxy statements
  2. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. PRER14A Preliminary revised proxy soliciting materials
  5. PREM14A Preliminary proxy statement relating to a merger, acquisition, or disposition
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements

Other 22

  1. 144 Filing for proposed sale of securities under Rule 144
  2. 144/A Filing for proposed sale of securities under Rule 144
  3. 144 Filing for proposed sale of securities under Rule 144
  4. EFFECT Notice of Effectiveness
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. UPLOAD Letter (PDF)
  7. EFFECT Notice of Effectiveness
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. UPLOAD Letter (PDF)
  10. EFFECT Notice of Effectiveness

All 22 other filings